Viral Immunologists are researchers dedicated to understanding the complex relationship between the immune system and viruses. Their work focuses on how the body’s immune system detects and responds to viral infections, specifically how antibodies, T cells, and other immune components work together to neutralize viruses. These experts also study how viruses like HIV, hepatitis, influenza, and coronaviruses can evade the immune system, leading to chronic infections or immune suppression. Through this research, viral immunologists uncover crucial insights into viral pathogenesis, which aids in developing vaccines and therapies that enhance the body’s immune response to combat viral infections.
Viral immunologists play a vital role in designing vaccines and therapeutic interventions to prevent and treat viral diseases. They contribute to creating vaccines that induce strong, long-lasting immunity, and help develop antiviral drugs that target specific viral components. Their expertise is also integral to the development of immune-based therapies, such as monoclonal antibodies, that can help boost the immune system’s ability to fight off infections. Viral immunologists are essential in advancing the fight against viral infections, offering innovative solutions to improve global health. Their continued research is pivotal in shaping future vaccine and treatment strategies, offering hope for controlling viral outbreaks worldwide.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States